Benzofurans as suppressors of neurodegeneration
View Patent ↗A compound of the formula: wherein R 1 and R 2 each is H or a hydrocarbon group which may be substituted, or R 1 and R 2 form a 3- to 8-membered carbo or heterocyclic ring which may be substituted; R 3 is H, a lower alkyl which may be substituted or an aromatic group which may be substituted; R 4 is (1) an aromatic group which may be substituted, (2) an aliphatic hydrocarbon group substituted by an aromatic group which may be substituted, which hydrocarbon group may be further substituted or (3) an acyl; X and Y each is oxygen or sulfur which may be oxidized; and ring A is a benzene ring which may be further substituted, or a salt thereof, is useful for an agent for suppressing neurodegeneration.
1. A compound of the formula:
wherein R 1 and R 2 are each a C 1-6 alkyl or R 1 and R 2 form, taken together with the adjacent carbon atom, a piperidine optionally substituted by 1 to 3 substituents selected from the group consisting of C 1-6 alkyl, C 6-14 aryl and C 7-16 aralkyl;
R 3 is a phenyl optionally substituted by 1 to 3 substituents selected from the group consisting of halogen atoms, C 1-6 alkyl, C 1-6 alkoxy, amino, mono-C 1-6 alkylamino and di-C 1-6 alkylamino;
R 4 is
(i) C 1-6 alkyl substituted by a phenyl or pyridyl, each of which is optionally substituted by 1 to 3 substituents selected from the group consisting of halogen atoms, C 1-6 alkyl, C 1-6 alkoxy, hydroxy, amino, mono-C 1-6 alkylamino, di-C 1-6 alkylamino and carboxy, or
(ii) an acyl of the formula: —(C═O)—R 5′ wherein R 5′ is a phenyl or phenyl-C 1-6 alkyl, each of which is optionally substituted by 1 to 3 substituents selected from the group consisting of halogen atoms, C 1-6 alkyl, C 1-6 alkoxy, hydroxy, amino, mono-C 1-6 alkylamino, di-C 1-6 alkylamino and carboxy;
X is an oxygen atom;
Y is an oxygen atom; and
ring A is a benzene ring which is optionally further substituted by 1 to 3 substituents selected from the group consisting of halogen atoms, halogenated or unhalogenated C 1-6 alkyl, halogenated or unhalogenated C 1-6 alkoxy, amino, mono-C 1-6 alkylamino and di-C 1-6 alkylamino,
provided that when is a single bond, R 4 is not acyl, and salts thereof.
2. A compound of the formula:
wherein R 1 and R 2 are each C 1-6 alkyl or R 1 and R 2 form, taken together with the adjacent carbon atom, a piperidine substituted by a C 1-6 alkyl or a C 7-16 aralkyl;
R 3 is a phenyl optionally substituted by 1 to 3 substituents selected from the group consisting of (1) C 1-6 alkyl, (2) di-C 1-6 alkylamino and (3) 6-membered saturated cyclic amino optionally substituted by a C 1-6 alkyl,
R 4 is
(i) a phenyl optionally substituted by 1 to 3 substituents selected from the group consisting of nitro and C 1-6 alkyl-carboxamido,
(ii) a C 1-6 alkyl or C 2-6 alkenyl group substituted by 1 to 3 of phenyl, quinolyl or pyridyl, each of which is optionally substituted by 1 to 3 substituents selected from the group consisting of C 1-6 alkoxy, C 1-6 alkylthio, C 1-6 alkoxy-carbonyl, C 1-6 alkylsulfonyl and C 1-6 alkylsulfinyl, which C 1-6 alkyl or C 2-6 alkenyl group is optionally further substituted by a phenyl, carboxy or C 1-6 alkoxy-carbonyl, or
(iii) an acyl of the formula: —(C═O)—R 5″
wherein R 5″ is phenyl substituted by a C 1-6 alkoxy; and ring A′ is a benzene ring which is optionally further substituted by 1 to 3 C 1-6 alkyl, provided that when is a single bond, R 4 is not acyl, and salts thereof.
3. 3-(4-isopropylphenyl)-2,4,6,7-tetramethylbenzofuran-5-yl 4-methoxybenzoate, 3-(4 isopropylphenyl)-5-(4-methoxybenzyloxy)-2,4,6,7-tetramethylbenzofuran, 3-(4-isopropylphenyl)-5-(4-methoxybenzyloxy)-1′,4,6,7-tetramethylspiro(benzofuran-2(3H), 4′-piperidine), or a salt thereof.
4. A process for producing a compound of claim 1 , which comprises reacting a compound of the formula:
wherein each symbol is as defined in claim 1 , or a salt thereof with a compound of the formula: R 4 -L wherein L represents a leaving group and R 4 is as defined in claim 1 , or salt thereof.
5. A pharmaceutical composition which comprises a compound of claim 1 , and a pharmaceutically acceptable carrier, excipient or diluent.
6. 3-(4-Isopropylphenyl)-5-(4-methoxybenzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran.